ENTRY       D12648                      Drug
NAME        Quisovalimab (USAN/INN)
FORMULA     C6414H9880N1692O2022S40
EXACT_MASS  144239.1127
MOL_WEIGHT  144327.8002
SEQUENCE    (Heavy chain)
            QVQLQQWGAG LLKPSETLSL TCAVYGGSFS GYNWHWIRQP PGKGLEWIGE ITHSGSTNYN
            PSLKSRVTIS VDTSKNQFSL KLSSVTAADT AVYYCVREIA VAGTGYYGMD VWGQGTTVTV
            SSASTKGPSV FPLAPCSRST SESTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ
            SSGLYSLSSV VTVPSSSLGT KTYTCNVDHK PSNTKVDKRV ESKYGPPCPP CPAPEFEGGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSQ EDPEVQFNWY VDGVEVHNAK TKPREEQFNS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKGL PSSIEKTISK AKGQPREPQV YTLPPSQEEM
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS RLTVDKSRWQ
            EGNVFSCSVM HEALHNHYTQ KSLSLSLG
            (Light chain)
            AIQLTQSPSS LSASVGDRVT ITCRASQGIN SAFAWYQQKP GKAPKLLIYD ASSLESGVPS
            RFSGSGSGTD 	FTLTISSLQP EDFATYYCQQ FNSYPLTFGG GTKVEIKRTV
            AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD
            STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H95, H136-L214, H149-H205, H228-H'228, H231-H'231, H263-H323, H369-H427, H'22-H'95, H'136-L'214, H'149-H'205, H'263-H'323, H'369-H'427, L23-L88, L134-194, L'23-L'88, L'134-L194)
  TYPE      Peptide
EFFICACY    Anti-inflammatory
  TYPE      Monoclonal antibody
COMMENT     Treatment of Crohn's disease, prevention of ARDS in patients with COVID-19
TARGET      TNFSF14 [HSA:8740] [KO:K05477]
  PATHWAY   hsa04060(8740)  Cytokine-cytokine receptor interaction
            hsa04061(8740)  Viral protein interaction with cytokine and cytokine receptor
            hsa04064(8740)  NF-kappa B signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Tumor necrosis factors
                TNFSF14
                 D12648  Quisovalimab (USAN/INN)
DBLINKS     CAS: 2427667-03-4
///
